These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30350166)

  • 1. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.
    Lee JH; Park CM; Joo I; Suh YJ; Hwang EJ; Kim H; Goo JM
    Eur Radiol; 2019 Aug; 29(8):4303-4314. PubMed ID: 30350166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study.
    Bhattacharjya S; Aggarwal R; Davidson BR
    Br J Cancer; 2006 Jul; 95(1):21-6. PubMed ID: 16804525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
    Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
    Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
    Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
    JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
    Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
    Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
    Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
    Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
    Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
    J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
    Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
    Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
    Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
    Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yield of routine imaging after curative colorectal cancer treatment.
    Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
    Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E; Mihailović J; Nikoletić K; Srbovan D
    Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.
    Kim C; Kim WR; Kim KY; Chon HJ; Beom SH; Kim H; Jung M; Shin SJ; Kim NK; Ahn JB
    Clin Colorectal Cancer; 2018 Sep; 17(3):e513-e518. PubMed ID: 29661621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
    Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
    PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U; You J; McSweeney S; Freeman M; Hendler A
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
    Makis W; Kurzencwyg D; Hickeson M
    Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and risk factors for colorectal cancer recurrence.
    Dogan L; Karaman N; Yilmaz KB; Ozaslan C; Atalay C; Altinok M
    J BUON; 2010; 15(1):61-7. PubMed ID: 20414929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.